Kolexia
Goutelle Sylvain
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
167 Activités
184 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie grave Maladies transmissibles Tuberculose Ostéomyélite Atteinte rénale aigüe Arthrite infectieuse Infections osseuses Mauvais usage des médicaments prescrits Pneumopathie infectieuse

Industries

MSD
4 collaboration(s)
Dernière en 2023
Menarini
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis.
The Journal of antimicrobial chemotherapy   07 février 2024
Daptomycin pharmacokinetic/pharmacodynamic target in staphylococcal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   17 janvier 2024
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study.
The Journal of antimicrobial chemotherapy   10 novembre 2023
Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication.
Therapeutic drug monitoring   08 novembre 2023
PHASAL-GA: Thymoglobulin® Pharmacokinetics for Graft-versus Host Disease in Children and Adults Undergoing Hematopoietic Stem Cell Transplantation
Essai Clinique (Hospices Civils de Lyon)   27 septembre 2023
AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?
Anaesthesia, critical care & pain medicine   28 juillet 2023
Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   19 juin 2023
Defining standard and high dosages for beta-lactams administered by intermittent, prolonged or continuous infusion: A PK/PD simulation study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Optimal dosage regimens of cefiderocol administered by short or continuous infusion: A PK/PD simulation study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Etude de cohorte sur huit ans de la tolérance au linézolide dans un CRIOAc : pas d'influence de l'âge sur la survenue et la gravité des effets indésirables
Journées Nationales de l'Infectiologie 2023   01 mai 2023